We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+45.29%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$483M
AUM Growth
+$23M
(+5%)
Cap. Flow
-$62.1M
Cap. Flow
% of AUM
-12.86%
Top 10 Holdings %
Top 10 Hldgs %
9.87%
Holding
378
New
132
Increased
14
Reduced
97
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLX Energy Services
KLXE
|
+$3.31M |
| 2 |
Par Pacific Holdings
PARR
|
+$3.1M |
| 3 |
A10 Networks
ATEN
|
+$3.05M |
| 4 |
Federal Signal
FSS
|
+$2.71M |
| 5 |
Tidewater
TDW
|
+$2.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
+$5.93M |
| 2 |
Cogent Biosciences
COGT
|
+$5.04M |
| 3 |
Lantheus
LNTH
|
+$4.84M |
| 4 |
Sensus Healthcare
SRTS
|
+$4.1M |
| 5 |
Cytokinetics
CYTK
|
+$3.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.56% |
| 2 | Industrials | 17.86% |
| 3 | Technology | 16.26% |
| 4 | Energy | 11.48% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
EXL Service
EXLS
$5.25B
| $1.45M | 0.3% |
42,890
-17,270
| -29% | -$600K |
|
|
PWSC
152
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $1.45M | 0.3% |
+62,950
| New | +$1.23M |
|
153
RenaissanceRe
RNR
$13.4B
| $1.43M | 0.3% |
+7,775
| New | +$1.31M |
|
154
Celsius Holdings
CELH
$6.08B
| $1.43M | 0.3% |
41,163
-28,611
| -41% | -$933K |
|
155
Silgan Holdings
SLGN
$4.39B
| $1.43M | 0.3% |
+27,525
| New | +$1.35M |
|
|
AVTA
156
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.42M | 0.29% |
55,494
-15,854
| -22% | -$363K |
|
157
Curtiss-Wright
CW
$26.4B
| $1.41M | 0.29% |
+8,467
| New | +$1.41M |
|
158
Tiptree Inc
TIPT
$667M
| $1.39M | 0.29% |
+100,668
| New | +$1.3M |
|
159
Fabrinet
FN
$19.5B
| $1.39M | 0.29% |
10,847
-113
| -1% | -$13.5K |
|
160
Aldeyra Therapeutics
ALDX
$95.9M
| $1.38M | 0.29% |
198,228
-35,410
| -15% | -$202K |
|
161
NWPX Infrastructure Inc
NWPX
$1.14B
| $1.37M | 0.28% |
40,735
| – | – |
|
162
Allegro MicroSystems
ALGM
$7.91B
| $1.37M | 0.28% |
+45,673
| New | +$1.25M |
|
163
WillScot Mobile Mini Holdings
WSC
$4.67B
| $1.37M | 0.28% |
+30,316
| New | +$1.36M |
|
164
Parsons
PSN
$5.12B
| $1.36M | 0.28% |
+29,495
| New | +$1.36M |
|
165
Purple Innovation
PRPL
$39.3M
| $1.36M | 0.28% |
+11,379
| New | +$1.24M |
|
|
ATXS
166
DELISTED
Astria Therapeutics
ATXS
| $1.36M | 0.28% |
+91,345
| New | +$942K |
|
167
Belden
BDC
$5.05B
| $1.36M | 0.28% |
18,863
-3,966
| -17% | -$288K |
|
168
Performance Food Group
PFGC
$18B
| $1.36M | 0.28% |
+23,212
| New | +$1.26M |
|
169
RLI Corp
RLI
$5.91B
| $1.35M | 0.28% |
+20,526
| New | +$1.28M |
|
|
STR
170
DELISTED
Sitio Royalties
STR
| $1.33M | 0.28% |
+46,103
| New | +$1.33M |
|
171
Noble Corp
NE
$6.5B
| $1.32M | 0.27% |
+35,102
| New | +$1.25M |
|
172
Lattice Semiconductor
LSCC
$18.3B
| $1.32M | 0.27% |
+20,366
| New | +$1.23M |
|
173
Hallador Energy
HNRG
$698M
| $1.31M | 0.27% |
131,322
-77,712
| -37% | -$640K |
|
174
Harmony Biosciences
HRMY
$2.26B
| $1.31M | 0.27% |
+23,738
| New | +$1.31M |
|
|
TERN
175
DELISTED
Terns Pharmaceuticals
TERN
| $1.3M | 0.27% |
+128,186
| New | +$853K |
|
Similar funds
RWM
MCM
HP
OMG
ICCFIA
WFAL
WCM
TSS
EAM Investors's Q4 2022 Portfolio in Review
As of Q4 2022, EAM Investors held 378 positions worth $483M, up 5% from $460M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
EAM Investors withdrew a net $62.1M in Q4 2022, closing 129 positions and reducing 97 holdings. Its most notable exit was Concert Pharmaceuticals, Inc., an estimated $5.93M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Technology.
Against the trend, EAM Investors opened a new position in KLX Energy Services worth $4.07M.
- EAM Investors's largest Q4 2022 buy was KLX Energy Services: 234,913 shares worth $4.07M.
- EAM Investors added most to Modine Manufacturing in Q4 2022, an estimated $1.28M increase.
- EAM Investors's biggest Q4 2022 reduction was Aehr Test Systems, cutting an estimated $3.09M.
- EAM Investors fully exited Concert Pharmaceuticals, Inc. in Q4 2022, selling an estimated $5.93M.
- EAM Investors's ten largest holdings make up 9.9% of its $483M portfolio in Q4 2022.
- EAM Investors opened 132 new positions and closed 129 in Q4 2022.
- EAM Investors's portfolio value rose 5% quarter-over-quarter to $483M.
Based on EAM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.